Stephanie H. Cholensky

University of North Carolina (UNC) at Chapel Hill, Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery

102 Ridge Road

Chapel Hill, NC 27514

United States

SCHOLARLY PAPERS

1

DOWNLOADS

32

SSRN CITATIONS

0

CROSSREF CITATIONS

1

Scholarly Papers (1)

1.

Discovery and Characterization of a Cellularly Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7

Number of pages: 104 Posted: 02 May 2019
University of North Carolina (UNC) at Chapel Hill, Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, Vienna Biocenter, Austrian Academy of Sciences, Institute of Molecular Biotechnology, University of North Carolina (UNC) at Chapel Hill, Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, Vienna Biocenter, Austrian Academy of Sciences, Institute of Molecular Biotechnology, University of North Carolina (UNC) at Chapel Hill, School of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill, Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina (UNC) at Chapel Hill, Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina (UNC) at Chapel Hill, Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina (UNC) at Chapel Hill, School of Medicine, Lineberger Comprehensive Cancer Center, Vienna Biocenter, Research Institute of Molecular Pathology, University of Texas at Houston, MD Anderson Cancer Center, Department of Epigenetics and Molecular Carcinogenesis, National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), Division of Preclinical Innovation, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Epigenetics and Molecular Carcinogenesis, University of North Carolina (UNC) at Chapel Hill, School of Medicine, Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill, Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina (UNC) at Chapel Hill, School of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill, Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, Vienna Biocenter, Austrian Academy of Sciences, Institute of Molecular Biotechnology and University of North Carolina (UNC) at Chapel Hill, Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery
Downloads 32 (480,492)
Citation 1

Abstract:

Loading...